At any time, most cancer patients are receiving a treatment that does not significantly benefit them while enduring bodily and financial toxicity. Aiming to guide each patient to the most optimal treatment, precision medicine has been expanding from genetic mutations to other drivers of clinical outcome. There has been a concerted effort to create "avatars" of patient tumors for testing and selecting therapies before administering them into patients.
Researchers from the University of Jyväskylä and the Central Finland Health Care District have developed an AI based neural network to detect an early knee osteoarthritis from x-ray images. AI was able to match a doctors’ diagnosis in 87% of cases. The result is important because x-rays are the primary diagnostic method for early knee osteoarthritis.
COVID-19 and its latest Omicron strains continue to cause infections globally. Serology (blood) and molecular tests are the two most commonly used methods for rapid COVID-19 testing. Because COVID-19 tests use different mechanisms, they vary significantly. Molecular tests measure the presence of viral SARS-CoV-2 RNA while serology tests detect the presence of antibodies triggered by the SARS-CoV-2 virus.
The human genome is three billion letters of code, and each person has millions of variations. While no human can realistically sift through all that code, computers can. Artificial intelligence (AI) programs can find patterns in the genome related to disease much faster than humans can. They also spot things that humans miss.
Researchers at the University of Southern California Alfred E. Mann Department of Biomedical Engineering have developed a "heart attack on a chip," a device that could one day serve as a testbed to develop new heart drugs and even personalized medicines.
Company claims are leaping ahead of medical science in promoting the use of smartwatches to screen for heart rhythm disorders.
That's the conclusion of a UC San Francisco cardiologist who specializes in arrhythmias and was among the first to explore the potential of smartwatches to alert wearers about possible atrial fibrillation (AF), a serious condition that can sometimes lead to deadly strokes.
One in nine women in the developed world will be diagnosed with breast cancer at some point in her life. The prevalence of breast cancer is increasing, an effect caused in part by the modern lifestyle and increased lifespans. Thankfully, treatments are becoming more efficient and more personalized. However, what isn't increasing - and is in fact decreasing - is the number of pathologists, or the doctors whose specialization is examining body tissues to provide the specific diagnosis necessary for personalized medicine.